Drupal.behaviors.print = function(context) {window.print();window.close();}>
Tekmira Acquires License to Novel RNAi Technology for Therapeutic Development
August 25, 2011
Tekmira Acquires License to Novel RNAi Technology for Therapeutic Development
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Tekmira Releases Phase I Cancer Drug Data, Plans Phase II Trial in Neuroendocrine Tumors
April 11, 2013 / Gene Silencing News
Tekmira to Present Cancer Drug Data at AACR, Aims for Phase II by Year-End
March 28, 2013 / Gene Silencing News
Tekmira Provides Pipeline Update, Eyes Agricultural Market
February 14, 2013 / Gene Silencing News
DoD Restarts Ebola Program with Tekmira
October 4, 2012 / Gene Silencing News
Hold on Tekmira, DoD Ebola Collaboration Extended for Additional Month
September 6, 2012 / Gene Silencing News